Penumbra, Inc. (PEN)
323.79
-1.39
(-0.43%)
USD |
NYSE |
Aug 24, 16:00
323.79
0.00 (0.00%)
After-Hours: 20:00
Penumbra Enterprise Value : 12.36B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 12.36B |
| August 20, 2026 | 12.31B |
| August 19, 2026 | 12.43B |
| August 18, 2026 | 12.35B |
| August 17, 2026 | 12.44B |
| August 14, 2026 | 12.44B |
| August 13, 2026 | 12.42B |
| August 12, 2026 | 12.42B |
| August 11, 2026 | 12.41B |
| August 10, 2026 | 12.39B |
| August 07, 2026 | 12.34B |
| August 06, 2026 | 12.35B |
| August 05, 2026 | 12.28B |
| August 04, 2026 | 12.32B |
| August 03, 2026 | 12.28B |
| July 31, 2026 | 12.21B |
| July 30, 2026 | 12.15B |
| July 29, 2026 | 12.16B |
| July 28, 2026 | 12.16B |
| July 27, 2026 | 12.14B |
| July 24, 2026 | 12.11B |
| July 23, 2026 | 12.08B |
| July 22, 2026 | 12.02B |
| July 21, 2026 | 12.06B |
| July 20, 2026 | 12.08B |
| Date | Value |
|---|---|
| July 17, 2026 | 12.09B |
| July 16, 2026 | 12.14B |
| July 15, 2026 | 12.03B |
| July 14, 2026 | 12.01B |
| July 13, 2026 | 12.12B |
| July 10, 2026 | 12.08B |
| July 09, 2026 | 12.08B |
| July 08, 2026 | 12.05B |
| July 07, 2026 | 12.09B |
| July 06, 2026 | 12.09B |
| July 02, 2026 | 12.10B |
| July 01, 2026 | 12.02B |
| June 30, 2026 | 11.99B |
| June 29, 2026 | 12.01B |
| June 26, 2026 | 12.05B |
| June 25, 2026 | 12.08B |
| June 24, 2026 | 12.04B |
| June 23, 2026 | 12.09B |
| June 22, 2026 | 12.04B |
| June 18, 2026 | 12.07B |
| June 17, 2026 | 12.03B |
| June 16, 2026 | 12.12B |
| June 15, 2026 | 12.11B |
| June 12, 2026 | 12.13B |
| June 11, 2026 | 12.12B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 85.09B |
| Globus Medical, Inc. | 11.18B |
| Abbott Laboratories | 229.49B |
| AngioDynamics, Inc. | 613.87M |
| Teleflex, Inc. | 8.440B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 34.81M |
| Revenue (Quarterly) | 390.05M |
| Total Expenses (Quarterly) | 355.24M |
| EPS Diluted (Quarterly) | 0.8797 |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 8.92% |
| Earnings Yield | 1.26% |
| Operating Earnings Yield | 1.47% |
| Normalized Earnings Yield | 1.258 |